Barbara J. Ring

5.7k total citations
59 papers, 4.7k citations indexed

About

Barbara J. Ring is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Barbara J. Ring has authored 59 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pharmacology, 22 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Barbara J. Ring's work include Pharmacogenetics and Drug Metabolism (42 papers), Drug Transport and Resistance Mechanisms (17 papers) and Analytical Chemistry and Chromatography (6 papers). Barbara J. Ring is often cited by papers focused on Pharmacogenetics and Drug Metabolism (42 papers), Drug Transport and Resistance Mechanisms (17 papers) and Analytical Chemistry and Chromatography (6 papers). Barbara J. Ring collaborates with scholars based in United States, United Kingdom and Switzerland. Barbara J. Ring's co-authors include Steven Wrighton, Mark VandenBranden, James A. Eckstein, Sean Ekins, S N Binkley, Jennifer S. Gillespie, Stephen D. Hall, Jennifer Witcher, John‐Michael Sauer and Mitchell A. Hamman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Barbara J. Ring

59 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara J. Ring United States	36	2.7k	1.5k	1.0k	641	625	59	4.7k
Kan Chiba Japan	41	2.8k 1.0×	2.0k 1.4×	1.6k 1.5×	1.0k 1.6×	514 0.8×	158	7.2k
M. S. Lennard United Kingdom	36	2.4k 0.9×	1.1k 0.7×	774 0.8×	847 1.3×	291 0.5×	114	4.6k
Miia Turpeinen Finland	40	2.2k 0.8×	977 0.7×	972 1.0×	448 0.7×	438 0.7×	123	5.6k
Tatsuji Iga Japan	39	1.6k 0.6×	1.8k 1.2×	1.4k 1.4×	1.1k 1.7×	230 0.4×	340	5.8k
Noriaki Shimada Japan	57	2.4k 0.9×	1.4k 1.0×	1.8k 1.8×	521 0.8×	353 0.6×	207	9.6k
Jack Uetrecht Canada	53	3.4k 1.3×	1.4k 0.9×	1.7k 1.7×	1.8k 2.8×	639 1.0×	199	8.8k
J. Brian Houston United Kingdom	44	3.7k 1.4×	2.4k 1.6×	1.2k 1.2×	583 0.9×	706 1.1×	119	5.7k
Mark VandenBranden United States	24	2.4k 0.9×	1.3k 0.9×	615 0.6×	361 0.6×	246 0.4×	28	3.1k
Nina Isoherranen United States	44	1.8k 0.7×	1.1k 0.7×	2.2k 2.1×	754 1.2×	339 0.5×	167	6.0k
Larry C. Wienkers United States	33	2.6k 1.0×	1.2k 0.9×	947 0.9×	551 0.9×	571 0.9×	79	3.9k

Countries citing papers authored by Barbara J. Ring

Since Specialization

Citations

This map shows the geographic impact of Barbara J. Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. Ring more than expected).

Fields of papers citing papers by Barbara J. Ring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara J. Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. Ring. The network helps show where Barbara J. Ring may publish in the future.

Co-authorship network of co-authors of Barbara J. Ring

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara J. Ring. A scholar is included among the top collaborators of Barbara J. Ring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara J. Ring. Barbara J. Ring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hutzler, J. Matthew, et al.. (2015). Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists. Drug Metabolism and Disposition. 43(12). 1917–1928. 46 indexed citations

Ring, Barbara J., Steven Wrighton, & Michael A. Mohutsky. (2014). Reversible Mechanisms of Enzyme Inhibition and Resulting Clinical Significance. Methods in molecular biology. 1113. 37–56. 35 indexed citations

Wickremsinhe, Enaksha, Anne H. Dantzig, Stephen D. Hall, et al.. (2012). Pharmacogenomics of Gemcitabine Metabolism: Functional Analysis of Genetic Variants in Cytidine Deaminase and Deoxycytidine Kinase. Drug Metabolism and Disposition. 41(3). 541–545. 32 indexed citations

Vuppugalla, Ragini, Punit Marathe, Handan He, et al.. (2011). PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach. Journal of Pharmaceutical Sciences. 100(10). 4111–4126. 49 indexed citations

Lobo, Evelyn D., Richard F. Bergstrom, Shobha Reddy, et al.. (2008). In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine. Clinical Pharmacokinetics. 47(3). 191–202. 64 indexed citations

Mohutsky, Michael A., Jenny Y. Chien, Barbara J. Ring, & Steven Wrighton. (2006). Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations. Pharmaceutical Research. 23(4). 654–662. 40 indexed citations

Li, Li, Todd D. Porter, Neil S. Jensen, et al.. (2006). NEW CYTOCHROME P450 2D6*56 ALLELE IDENTIFIED BY GENOTYPE/PHENOTYPE ANALYSIS OF CRYOPRESERVED HUMAN HEPATOCYTES. Drug Metabolism and Disposition. 34(8). 1411–1416. 12 indexed citations

Lamba, Vishal, Jatinder K. Lamba, Kazuto Yasuda, et al.. (2003). Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression. Journal of Pharmacology and Experimental Therapeutics. 307(3). 906–922. 320 indexed citations

Ring, Barbara J., Jennifer S. Gillespie, James A. Eckstein, & Steven Wrighton. (2002). Identification of the Human Cytochromes P450 Responsible for Atomoxetine Metabolism. Drug Metabolism and Disposition. 30(3). 319–323. 110 indexed citations

10.

Ring, Barbara J., et al.. (2001). A novel testosterone 6β-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro. Journal of Pharmacological and Toxicological Methods. 46(2). 117–123. 30 indexed citations

11.

Ekins, Sean, et al.. (2000). Present and future in vitro approaches for drug metabolism. Journal of Pharmacological and Toxicological Methods. 44(1). 313–324. 157 indexed citations

12.

Wrighton, Steven & Barbara J. Ring. (1999). PREDICTING DRUG INTERACTIONS AND PHARMACOKINETIC VARIABILITY WITH IN VITRO METHODS: THE OLANZAPINE EXPERIENCE*. Drug Metabolism Reviews. 31(1). 15–28. 16 indexed citations

13.

Wrighton, Steven, Mark VandenBranden, & Barbara J. Ring. (1996). The human drug metabolizing cytochromes P450. Journal of Pharmacokinetics and Biopharmaceutics. 24(5). 461–473. 139 indexed citations

14.

Ring, Barbara J.. (1996). In citro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A. British Journal of Pharmacology. 41. 181–186. 1 indexed citations

15.

Goldberg, Mark J., Barbara J. Ring, K A DeSante, et al.. (1996). Effect of Dirithromycin on Human CYP3AIn Vitroand on Pharmacokinetics and Pharmacodynamics of TerfenadineIn Vivo. The Journal of Clinical Pharmacology. 36(12). 1154–1160. 12 indexed citations

16.

Ring, Barbara J., S N Binkley, Mark VandenBranden, & Steven Wrighton. (1996). In vitrointeraction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A. British Journal of Clinical Pharmacology. 41(3). 181–186. 93 indexed citations

17.

Ring, Barbara J., et al.. (1994). In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.. Drug Metabolism and Disposition. 22(3). 352–357. 24 indexed citations

18.

Gallenberg, Lori A., Barbara J. Ring, & Mary Jo Vodicnik. (1990). The influence of time of maternal exposure to 2,4,5,2′,4′,5′-hexachlorobiphenyl on its accumulation in their nursing offspring. Toxicology and Applied Pharmacology. 104(1). 1–8. 12 indexed citations

19.

Holcenberg, John S., et al.. (1987). Chronic effects of fractionated renal irradiation on the pharmacokinetics of intravenous methotrexate. International Journal of Radiation Oncology*Biology*Physics. 13(5). 759–764. 5 indexed citations

20.

Holcenberg, John S., Luis Borella, Bruce M. Camitta, & Barbara J. Ring. (1979). Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(8). 3145–51. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact